Metformin induces Ferroptosis by inhibiting UFMylation of SLC7A11 in breast cancer.
Yang J, Zhou Y, Xie S, Wang J, Li Z, Chen L, Mao M, Chen C, Huang A, Chen Y, Zhang X, Khan NUH, Wang L, Zhou J. · 2021
Read Metformin induces Ferroptosis by inhibiting UFMylation of SLC7A11 in breast cancer. by Yang J, Zhou Y, Xie S, Wang J, Li Z, Chen L, Mao M, Chen C, Huang A, Chen Y, Zhang X, Khan NUH, Wang L, Zhou J. (2021) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc8223374.txt.
Description
Yang and co-authors show that metformin can drive ferroptosis in breast cancer cells. Ferroptosis is a newer form of cell death tied to iron and lipid damage. Approved drugs that trigger it could reach patients fast.
Metformin is a diabetes drug with hinted anti-cancer effects. The team traced its action to the protein SLC7A11. Metformin blocked a modification, called UFMylation, that protects that protein. With the shield gone, cancer cells slid into ferroptosis. The work names a precise step behind the drug's effect. It supports trials of old drugs in new roles.
Catalog record
| CREATOR | Yang J, Zhou Y, Xie S, Wang J, Li Z, Chen L, Mao M, Chen C, Huang A, Chen Y, Zhang X, Khan NUH, Wang L, Zhou J. |
|---|---|
| YEAR | 2021 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 74 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |